Quantitative fundus autofluorescence in non-neovascular age-related macular degeneration

Jorge Orellana-Rios, Sho Yokoyama, Julia M. Agee, Nayanika Challa, K. Bailey Freund, Lawrence A. Yannuzzi, R. Theodore Smith

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

BACKGROUND AND OBJECTIVE: To use quantitative fundus autofluorescence (qAF) to analyze different stages of non-neovascular age-related macular degeneration (AMD). PATIENTS AND METHODS: In this cohort study, 38 pseudophakic patients and 36 age-matched controls participated. We performed near-infrared, spectral-domain optical coherence tomography and qAF imaging on 31 pseudophakic eyes and controls of participants older than 60 years with non-neovascular AMD phenotypes using the Spectralis HRA + OCT (Heidelberg Engineering, Heidelberg, Germany). RESULTS: The patients included in this study had a mean age of 83.9 years, and 35.7% patients were men. Mean qAF was higher in control participants than in all patients with AMD (P <.001). According to non-neovascular AMD phenotype, mean qAF levels were significantly lower in eyes with subretinal drusenoid deposits than in control eyes (P <.05). The lowest mean qAF was in patients with geographic atrophy. CONCLUSION: Quantitative fundus autofluorescence of non-neovascular AMD decreases from normal to early to late AMD, suggesting that loss of lipofuscin fluorophores, not increase, signifies AMD progression.

Original languageEnglish
Pages (from-to)S34-S42
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume49
Issue number10
DOIs
StatePublished - Oct 2018

Fingerprint

Dive into the research topics of 'Quantitative fundus autofluorescence in non-neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Cite this